Explore the intricacies of the FDA's new classification for DNA-based tests measuring minimal residual disease in hematological malignancies. Learn how the shift to Class II with special controls impacts safety, effectiveness, and patient access, reducing regulatory...
2025
Showing 37–45 of 280 resultsSorted by latest
-
Trichloroethylene (TCE) Regulation Postponement under TSCA
$9.99 -
Beneficial Ownership Information Compliance Course
$49.99 -
Compliance with Updated Unaccompanied Children Program Rule
$9.99 -
Nonprescription Drug Products: Navigating New FDA Conditions
$19.99 -
Comprehensive Guide to Horse Protection Amendments
$9.99 -
FAA Rule: Flight Prohibition Over Libyan Airspace
$49.99 -
Patient Protection and Affordable Care Act: Proposed Marketplace Rule Analysis
$199.99 -
FAA Proposed Rule: Enhancing Lightning Strike Safety on Airbus A350
$9.99 -
Compliance with FAA Airworthiness Directive for Airbus Canada Airplanes
$19.99